News - BioPharm International

ADVERTISEMENT

News

NIH Seeks to Improve Vaccine Response with New Adjuvants

September 30, 2014

NIH seeks new therapeutic products to bolster the protective properties of vaccines.

New Report Details Players and Pipelines in the Biosimilar Space

September 30, 2014

A new Thomson Reuters BioWorld report outlines the more than 700 biosimilars that are currently in development and the emerging business opportunities that exist in the biopharmaceutical space.

Baxter International Plans to Open R&D Center for Baxalta

September 30, 2014

Baxter International announced it will form a R&D center in Cambridge, Massachusetts for its new biopharmaceutical company, Baxalta.

FDA Releases First-Ever Purple Book for Biosimilar Characterization

September 26, 2014

The Purple Book will list biologic and biosimilar products and will serve as a guide for interchangeability.

FDA and NIH Win Award for IP Licensing of Meningitis Vaccine

September 26, 2014

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

FDA Releases REMS Report

September 25, 2014

FDA report details risk mitigation projects.

NIH Funds Tissue Chip for Drug Screening

September 25, 2014

NIH continues funding for tissue chips to be used in the development of therapeutics.

UPS' Pain in the Supply Chain Results

September 23, 2014

Regulations, product protection, and cost management are top concerns of supply chain decision makers.

Merck KGaA Announces Acquisition of Sigma-Aldrich for $17 Billion

September 22, 2014

Merck KGaA will expand the reach of its EMD Millipore division with the purchase of life-sciences company Sigma-Aldrich.

ADVERTISEMENT

ADVERTISEMENT

Click here